SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000078003-19-000021
Filing Date
2019-04-30
Accepted
2019-04-30 08:58:02
Documents
5
Period of Report
2019-04-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pfe-03312019x8k.htm 8-K 31718
2 EXHIBIT 99.1 pfe-03312019xex99.htm EX-99.1 1538002
3 oldpfelogowhitea01a01a01a08.jpg GRAPHIC 95575
4 pfizerbiopharmalogo.jpg GRAPHIC 754449
5 upjohnlogo.jpg GRAPHIC 230605
  Complete submission text file 0000078003-19-000021.txt   3032732
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 19778744
SIC: 2834 Pharmaceutical Preparations